Exploring patient participation in reducing health-care-related safety risks
Exploring patient participation in reducing health-care-related safety risks
Exploring patient participation in reducing health-care-related safety risks
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Explor<strong>in</strong>g</strong> <strong>patient</strong> <strong>participation</strong> <strong>in</strong> reduc<strong>in</strong>g <strong>health</strong>-<strong>care</strong>-<strong>related</strong> <strong>safety</strong> <strong>risks</strong><br />
82<br />
Fig . 5 .2 . Relationship between <strong>patient</strong>s’ knowledge and the number of medic<strong>in</strong>es taken<br />
How many medic<strong>in</strong>es do you take every day?<br />
More than 7<br />
5–7<br />
3–5<br />
Up to 3<br />
%<br />
0 20 40 60 80 100<br />
Do you know the names and dosages of all medic<strong>in</strong>es you take?<br />
Almost two thirds said they discussed their medication dur<strong>in</strong>g every visit to the doctor,<br />
but it is not known what aspects of pharmacotherapy were covered <strong>in</strong> these discussions<br />
(for example, does the <strong>patient</strong> obta<strong>in</strong> answers to all their questions, does the doctor<br />
provide clear and <strong>patient</strong>-friendly <strong>in</strong>formation and does the <strong>patient</strong> understand the<br />
answers?).<br />
Regard<strong>in</strong>g discussions about medic<strong>in</strong>es taken, most (93%) claimed they, their family or<br />
an accompany<strong>in</strong>g person <strong>in</strong>itiated such conversations dur<strong>in</strong>g medical visits. This clearly<br />
shows there are problems <strong>related</strong> to drug use that require explanation and clarification.<br />
Only 7% of respondents (all women) stated that conversations had been started by the<br />
physician, which <strong>in</strong>dicates <strong>in</strong>sufficient pharmacotherapy surveillance and monitor<strong>in</strong>g by<br />
physicians and suggests that <strong>patient</strong>s are rarely asked about ADRs. It seems that doctors<br />
ma<strong>in</strong>ly refer to the written <strong>in</strong>formation <strong>in</strong> the <strong>patient</strong>’s file.<br />
Only 6% of respondents stated that the doctor mentioned or discussed potential<br />
<strong>in</strong>teractions <strong>related</strong> to the medic<strong>in</strong>es be<strong>in</strong>g taken: 94% of <strong>patient</strong>s may therefore not be<br />
aware that prescribed drugs might have <strong>in</strong>teractions with other medic<strong>in</strong>es or with OTC<br />
drugs and/or dietary supplement(s).<br />
The survey results suggest that few doctors were <strong>in</strong>terested <strong>in</strong> their <strong>patient</strong>s’ medication<br />
history. Only 6% of <strong>patient</strong>s stated that their doctor always asked about medic<strong>in</strong>es be<strong>in</strong>g<br />
taken before prescrib<strong>in</strong>g a new one (Fig. 5.3): over a third (37%) reported that it “never<br />
happens” and more than half (57%) that it was “sometimes” discussed. This implies<br />
that almost 40% of <strong>patient</strong>s are at risk of adverse <strong>in</strong>teractions, as the doctor – unless<br />
he or she has thoroughly consulted the <strong>patient</strong>’s file and the recorded <strong>in</strong>formation is<br />
complete – will not be aware of which medic<strong>in</strong>es have been taken recently and will not<br />
knowledgeably manage the risk of potential <strong>in</strong>teractions.<br />
Only one respondent <strong>in</strong>dicated that the doctor asked about previous ADEs when<br />
prescrib<strong>in</strong>g a new medication. Over a third (37%) confirmed that this “sometimes”<br />
happened but 61% (30 respondents) claimed the doctor never asked about this.<br />
Yes<br />
No